Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Infinityon Aug 29, 2023 7:27am
192 Views
Post# 35609347

RE:RE:RE:RE:Interim Data...

RE:RE:RE:RE:Interim Data...Funny it is the same pumpers, coming up with their own versions and excuses for a company's track record of extending on their time lines,  Yes they had legitimate reasons in the past due to Covid.  Now there is no more reason to extend their own time lines and keep issuing PP's instead of seeking a Joint venture.  It is IMPOSIBBLE that all Major Pharma companies are completely unaware of the clinical research conducted so far by TLT. This company is entirely run by one Man and one Man makes all the major business decisions.  A Joint venture will change that.  NO JV partner will agree to run this company as a one man show.  The underlying question is his relucance in losing control of a company that he built from scratch.  I am not questioning his integrity at all.
<< Previous
Bullboard Posts
Next >>